TNSN98087A1 - Composition pharmaceutique en aerosol - Google Patents

Composition pharmaceutique en aerosol

Info

Publication number
TNSN98087A1
TNSN98087A1 TNTNSN98087A TNSN98087A TNSN98087A1 TN SN98087 A1 TNSN98087 A1 TN SN98087A1 TN TNSN98087 A TNTNSN98087 A TN TNSN98087A TN SN98087 A TNSN98087 A TN SN98087A TN SN98087 A1 TNSN98087 A1 TN SN98087A1
Authority
TN
Tunisia
Prior art keywords
aerosol
inhaler
aerosol particles
pharmaceutical composition
low volatility
Prior art date
Application number
TNTNSN98087A
Other languages
English (en)
Inventor
Gaetano Brambilla
Raffaella Garzia
Brian Meakin
David Lewis
Davis Ganderton
Paolo Ventura
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN98087(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of TNSN98087A1 publication Critical patent/TNSN98087A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Abstract

UNE COMPOSITION A UTILISER DANS UN INHALATEUR EN AEROSOL, COMPRENANT UNE SUBSTANCE ACTIVE, UN PROPULSEUR CONTENANT UN HYDROFLUOROALCANE ET UN COSOLVANT. LA COMPOSITION CONTIENT, EN OUTRE, UN COMPOSANT DE FAIBLE VOLATILITE QUI EST AJOUTE POUR AUGMENTER LE DIAMETRE AERODYNAMIQUE MASSIQUE MOYEN (MMADI) DES PARTICULES D'AEROSOL LORS DE L'EXPLOITATION DE L'INHALATEUR. AVEC L'ADJONCTION D'UN COMPOSANT DE FAIBLE VOLATILITE, LE DIAMETRE AERODYNAMIQUE MASSIQUE MOYEN (MMAD) DES PARTICULES D'AEROSOL PEUT ETRE COMPARABLE A CELUI DES PARTICULES D'AEROSOL D'UN INHALATEUR AYANT LE CFC COMME PROPULSEUR.
TNTNSN98087A 1997-06-13 1998-06-12 Composition pharmaceutique en aerosol TNSN98087A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (1)

Publication Number Publication Date
TNSN98087A1 true TNSN98087A1 (fr) 2005-03-15

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98087A TNSN98087A1 (fr) 1997-06-13 1998-06-12 Composition pharmaceutique en aerosol

Country Status (45)

Country Link
EP (2) EP0920302B2 (fr)
JP (1) JP4380802B2 (fr)
KR (1) KR100546239B1 (fr)
CN (1) CN1138532C (fr)
AR (1) AR012977A1 (fr)
AT (1) ATE222751T1 (fr)
AU (1) AU729966B2 (fr)
BG (1) BG63906B1 (fr)
BR (1) BR9805993B1 (fr)
CA (1) CA2263445C (fr)
CO (1) CO4940408A1 (fr)
CZ (1) CZ295521B6 (fr)
DE (1) DE69807420T3 (fr)
DK (1) DK0920302T4 (fr)
DZ (1) DZ2516A1 (fr)
EA (1) EA001259B1 (fr)
EE (1) EE03664B1 (fr)
ES (1) ES2182351T5 (fr)
GB (1) GB2326334A (fr)
GE (1) GEP20012462B (fr)
HK (1) HK1022271A1 (fr)
HR (1) HRP980317B1 (fr)
HU (1) HU228487B1 (fr)
ID (1) ID21491A (fr)
IL (1) IL128484A (fr)
IN (1) IN189317B (fr)
IS (1) IS2435B (fr)
IT (1) IT1293803B1 (fr)
MA (1) MA26507A1 (fr)
ME (2) ME00333B (fr)
MY (1) MY119074A (fr)
NO (1) NO327775B1 (fr)
NZ (1) NZ334149A (fr)
PL (1) PL193721B1 (fr)
PT (1) PT920302E (fr)
RS (1) RS51274B (fr)
SA (1) SA98190821B1 (fr)
SI (1) SI0920302T2 (fr)
SK (1) SK284430B6 (fr)
TN (1) TNSN98087A1 (fr)
TR (1) TR199900288T1 (fr)
TW (1) TW555570B (fr)
UA (1) UA70289C2 (fr)
WO (1) WO1998056349A1 (fr)
ZA (1) ZA985136B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6479035B1 (en) 1999-09-11 2002-11-12 Smithkline Beecham Corporation Pharmaceutical formulation of fluticasone propionate
EP1231894B1 (fr) * 1999-11-23 2005-01-12 Glaxo Group Limited Formulations pharmaceutiques de salmeterol
DE60019167T2 (de) * 1999-12-24 2006-05-11 Glaxo Group Ltd., Greenford Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
CZ303833B6 (cs) * 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
TR200401980T4 (tr) 2001-07-02 2004-09-21 Chiesi Farmaceutici S.P.A. Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
EP1340503A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formule d'une solution pour aerosol contenant des dérivés d'esters de 3,17 estratrien pour administration pulmonale
EP1340492A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique
ES2779273T3 (es) 2002-03-01 2020-08-14 Chiesi Farm Spa Formulación superfina de formoterol
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
DE60216242T2 (de) * 2002-06-06 2007-05-24 Chiesi Farmaceutici S.P.A. Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen
WO2004071488A1 (fr) * 2003-02-04 2004-08-26 Chrysalis Technologies Incorporated Preparations de perfluorocarbure et d'hydrofluorocarbure et procedes de fabrication et d'utilisation de celles-ci
AU2004224367B2 (en) * 2003-03-20 2009-10-08 Boehringer Ingelheim Pharmaceuticals, Inc. Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
EP1915985A1 (fr) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation pour une dose mesurée utilisant des hydro-fluoro-alcanes en tant que propulseurs
EP1595531A1 (fr) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression
EA013428B1 (ru) 2004-07-02 2010-04-30 Бёрингер Ингельхайм Интернациональ Гмбх РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP2217278A1 (fr) * 2007-11-07 2010-08-18 AstraZeneca AB Formulations de poudre sèche comportant des dérivés de l'acide ascorbique
CN105854136A (zh) * 2010-09-06 2016-08-17 奇斯药制品公司 计量剂量吸入器和使用该计量剂量吸入器的方法
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
EP2819669B1 (fr) 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Nouvelle formulation de tiotropium contenant un gaz propulseur
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
WO2016018892A1 (fr) 2014-07-29 2016-02-04 3M Innovative Properties Company Procédé de préparation d'une composition pharmaceutique
WO2017167737A1 (fr) 2016-03-31 2017-10-05 Chiesi Farmaceutici S.P.A. Dispositif d'inhalation d'aérosol
EA201990501A1 (ru) * 2016-09-19 2019-09-30 Мехикем Флуор С.А. Де С.В. Фармацевтическая композиция

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005211A1 (fr) † 1986-03-10 1987-09-11 Kurt Burghart Preparation pharmaceutique et son procede de production
EP0259383B1 (fr) † 1986-03-10 1991-01-23 Kurt Dr. Burghart Produit pharmaceutique et son procede de preparation
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
DK0553298T3 (da) † 1990-10-18 1995-04-18 Minnesota Mining & Mfg Aerosolformulering omfattende beclomethason-17,21-dipropionat
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ES2269582T3 (es) † 1991-06-10 2007-04-01 Schering Corporation Formulaciones en aerosol sin clorofluorocarbonos.
DE69231992T2 (de) † 1991-06-10 2001-12-13 Schering Corp Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE69205177T2 (de) * 1991-12-12 1996-03-21 Glaxo Group Ltd Pharmazeutische Aerosolformulierung.
DK0617610T3 (da) * 1991-12-18 1997-10-06 Minnesota Mining & Mfg Suspensionsaerosolformuleringer.
EP0673240B1 (fr) * 1992-12-09 1999-03-24 Boehringer Ingelheim Pharmaceuticals Inc. Formulations de solutions medicinales aerosol stabilisees
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
JP3911290B2 (ja) † 1994-05-13 2007-05-09 アラダイム コーポレーション エアゾールを含む麻酔用処方
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
EP0914143A1 (fr) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Formulation d'une solution d'aerosol medicinal de cyclosporine a
WO1998024420A1 (fr) † 1996-12-04 1998-06-11 Bioglan Ireland (R & D) Limited Compositions pharmaceutiques et leurs dispositifs d'administration
JP2001511160A (ja) † 1997-02-05 2001-08-07 ヤゴ リサーチ アクチェンゲゼルシャフト 医学用エアゾール配合物

Also Published As

Publication number Publication date
CA2263445C (fr) 2008-09-09
PL193721B1 (pl) 2007-03-30
ID21491A (id) 1999-06-17
GB2326334A (en) 1998-12-23
ME00333B (me) 2011-02-10
CZ295521B6 (cs) 2005-08-17
PT920302E (pt) 2002-11-29
CA2263445A1 (fr) 1998-12-17
NZ334149A (en) 2000-07-28
DZ2516A1 (fr) 2004-11-08
KR100546239B1 (ko) 2006-01-26
DE69807420D1 (de) 2002-10-02
IT1293803B1 (it) 1999-03-10
YU6999A (sh) 2000-03-21
HRP980317B1 (en) 2002-06-30
DK0920302T3 (da) 2002-12-23
NO990594D0 (no) 1999-02-09
IL128484A (en) 2004-09-27
CN1138532C (zh) 2004-02-18
EP0920302B1 (fr) 2002-08-28
GB9712434D0 (en) 1997-08-13
EP0920302B2 (fr) 2006-06-21
IS4974A (is) 1999-02-11
ZA985136B (en) 1999-01-07
AU729966B2 (en) 2001-02-15
UA70289C2 (uk) 2004-10-15
NO327775B1 (no) 2009-09-21
SI0920302T1 (en) 2002-12-31
BG103221A (en) 1999-09-30
TW555570B (en) 2003-10-01
CZ46299A3 (cs) 1999-07-14
BR9805993A (pt) 1999-08-31
ES2182351T3 (es) 2003-03-01
HK1022271A1 (en) 2000-08-04
EA001259B1 (ru) 2000-12-25
BG63906B1 (bg) 2003-06-30
HU228487B1 (en) 2013-03-28
DE69807420T2 (de) 2003-05-08
GEP20012462B (en) 2001-06-25
SI0920302T2 (sl) 2006-10-31
IN189317B (fr) 2003-02-08
EP0920302A1 (fr) 1999-06-09
MY119074A (en) 2005-03-31
EE03664B1 (et) 2002-04-15
HUP0001339A3 (en) 2000-10-30
SK284430B6 (sk) 2005-04-01
HUP0001339A2 (hu) 2000-09-28
IL128484A0 (en) 2000-01-31
RS51274B (sr) 2010-12-31
DK0920302T4 (da) 2006-10-09
HRP980317A2 (en) 1999-04-30
SK17699A3 (en) 1999-07-12
MA26507A1 (fr) 2004-12-20
WO1998056349A1 (fr) 1998-12-17
EE9900055A (et) 1999-08-16
EP1219293A3 (fr) 2003-05-28
ITMI971798A1 (it) 1999-01-28
ATE222751T1 (de) 2002-09-15
IS2435B (is) 2008-10-15
MEP44008A (en) 2011-02-10
NO990594L (no) 1999-04-13
AR012977A1 (es) 2000-11-22
DE69807420T3 (de) 2006-11-16
CO4940408A1 (es) 2000-07-24
BR9805993B1 (pt) 2009-05-05
AU8626298A (en) 1998-12-30
EA199900201A1 (ru) 1999-06-24
JP2000516965A (ja) 2000-12-19
EP1219293A2 (fr) 2002-07-03
PL331531A1 (en) 1999-07-19
CN1229355A (zh) 1999-09-22
TR199900288T1 (xx) 1999-09-21
JP4380802B2 (ja) 2009-12-09
ES2182351T5 (es) 2007-03-16
KR20000068171A (ko) 2000-11-25
SA98190821B1 (ar) 2006-11-19

Similar Documents

Publication Publication Date Title
TNSN98087A1 (fr) Composition pharmaceutique en aerosol
TNSN01074A1 (fr) Formulations pharmaceutiques stables en solution pour inhalateurs sous pression a comptage de dose
Kennedy Jr Dermal toxicity of ammonium perfluorooctanoate
EA200000060A1 (ru) Фармацевтические композиции для нанесения на слизистую оболочку
HRP20000867B1 (en) Pharmaceutical formulations for aerosols with two or more active substances
BE901994A (fr) Comprimes de principes actifs pharmaceutiques a delitement rapide, stables au stockage.
FR2730637B1 (fr) Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
BE1003009A5 (fr) Nouvelles compositions pharmaceutiques a base de cyclosporines.
GB9126209D0 (en) Drug formulations for parenteral use
ATE314092T1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
EA199900991A1 (ru) Медицинские аэрозольные препараты
WO2001045503A3 (fr) Compositions et procedes de cryopreservation pour des lymphocytes circulants
BR0013919A (pt) Suspensão estável concentrada de pesticida
BR0007201A (pt) Composições incluindo agentes de preservação demalto-oligossacarìdeos reduzidos, e métodospara preservar um material
Samuel et al. Lead exposure in American black ducks after implementation of non-toxic shot
EP0904837A3 (fr) Catalyseur d'hydrosilylation et méthode d'hydrosilylation
TR200200841T2 (tr) Mukozaya uygulama için, siklesonid içeren farmasötik kompozisyon
EP0374796A3 (fr) Formulations d'émulsions stables de pesticides organiques insolubles dans l'eau
FR2406998A1 (fr) Batonnet deodorant contenant un bicarbonate
KR970701535A (ko) 비타민 E를 함유하는 에어로졸 약물 제형(Aerosol drug formulations containing vitamin'E)
JPS5572110A (en) Transfusion fluid for oxygen transfer
ES8100852A1 (es) Un metodo para la conservacion de plantas vivas
EP0333608A3 (fr) Composition antimousse, procédé pour la préparer et composition agrochimique la contenant
Sahilli THE ROLE OF GLUTATHIONE IN THE DETOXIFICA-TION OF PERCHLOROETHYLENE
JPS57136503A (en) Expellent for noxious mollusk